Location History:
- Lynnfield, MA (US) (1989)
- Essex County, MA (US) (1989)
Company Filing History:
2 out of 8,396 
2 out of 818 
Years Active: 1989
Title: John D. Groopman: Innovator in Toxicology Detection
Introduction
John D. Groopman, based in Lynnfield, MA, is a notable inventor recognized for his contributions to the field of toxicology through innovative detection methods. With two patents to his name, Groopman's work emphasizes the importance of accurate detection of low molecular weight toxic substances, showcasing his commitment to improving health and safety standards.
Latest Patents
Groopman's latest patents revolve around the development of an affinity column and a process designed for the detection of low molecular weight toxic compounds, such as aflatoxins. These patents introduce an affinity matrix that utilizes a specific monoclonal IgM antibody, which boasts an exceptional affinity constant of no less than about 1 x 10^9 liters per mole. His methods highlight rapidity, accuracy, reproducibility, and enable quantitative recovery of the harmful compositions of interest. This advancement signifies a major step forward in the field of hazardous substance detection.
Career Highlights
Throughout his career, John D. Groopman has been associated with prestigious institutions like the Massachusetts Institute of Technology and Boston University. His academic and research endeavors have significantly influenced the study of toxicology and its implications on public health. His innovative spirit and dedication have earned him recognition among fellow researchers and professionals in his field.
Collaborations
Groopman's innovation journey includes collaborations with notable peers such as Gerald N. Wogan and Frederick G. Bargoot. These partnerships have played a crucial role in enhancing the quality and impact of his research, leading to the successful development of his patented technologies.
Conclusion
In summary, John D. Groopman's contributions to the detection of low molecular weight toxic compounds have stood as a testament to his inventive capabilities and dedication to public health. His work not only exemplifies innovation in the scientific community but also serves as a critical resource for ensuring safety in various applications where toxic substances may pose significant risks.